Matthias Rothfuss

Title: Matthias Rothfuss: Innovator in Therapeutic Monoclonal Antibody Measurement

Introduction

Matthias Rothfuss is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the measurement of antibodies related to therapeutic monoclonal antibodies. His work is essential for improving patient outcomes in treatments involving these advanced therapies.

Latest Patents

Rothfuss holds a patent for an innovative assay designed for the measurement of antibodies binding to therapeutic monoclonal antibodies. The patent details methods and systems for determining the presence of anti-therapeutic monoclonal antibody antibodies (anti-TmAB AB) in vitro from samples taken from patients undergoing treatment with therapeutic monoclonal antibodies (TmAB). This invention also includes methods for identifying antigen-specific antibodies of a particular immunoglobulin class and for recognizing patients at risk of developing adverse drug reactions (ADRs) during TmAB treatment.

Career Highlights

Matthias Rothfuss is currently employed at Roche Diagnostics Operations, Inc., where he continues to advance research and development in the field of diagnostics. His expertise and innovative approach have positioned him as a key figure in the biotechnology sector.

Collaborations

Rothfuss collaborates with talented professionals, including Barbara Upmeier and Ursula Klause, who contribute to the success of his projects and innovations.

Conclusion

Matthias Rothfuss is a distinguished inventor whose work in the measurement of antibodies has the potential to enhance therapeutic strategies for patients. His contributions to biotechnology are invaluable and continue to shape the future of medical diagnostics.